A Global Collaboration for PF

24 months

PROGRAM TERM

Centre of Research Excellence in Pulmonary Fibrosis and Lung Foundation Australia

ORGANIZATIONS

Centre of Research Excellence in Pulmonary Fibrosis (CRE-PF) is a clinically focused research program funded by the Australian National Health and Medical Research Council.

Three Lakes Foundation is collaborating with CRE-PF and Lung Foundation Australia to share expertise, resources, and knowledge with the goal of accelerating diagnosis, treatment, and delivery of life-saving therapies for PF. By joining forces, we seek to improve understanding of PF, fast-track research internationally, and uncover ways to enhance quality of life for people living with PF/IPF.

The CRE-PF research projects are supervised by Tamera Corte, BSc, MBBS, FRACP, PhD. Dr. Corte is Clinical Associate Professor, Central Clinical School, Sydney Medical School, University of Sydney, Australia.

Breath Biopsy for Early PF Detection

Metabolic changes associated with IPF and interstitial lung abnormality (ILA) may lead to the production of unique, volatile, organic compounds (VOCs) detectable in breath.

EGCG for IPF

EGCG was discovered as an antifibrotic in pre-clinical in vivo studies and its mechanism of action blocking collagen accumulation published in 2017.

An Atlas of IPF Lung Cells

This research study was designed to identify the cellular changes that occur in the human lung cells as fibrosis develops.